Volume | 7,100 |
|
|||||
News | - | ||||||
Day High | 1.26 | Low High |
|||||
Day Low | 1.20 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Passage Bio Inc | PASG | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
1.22 | 1.20 | 1.26 | 1.20 | 1.24 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
169 | 7,100 | $ 1.21 | $ 8,608 | - | 0.5751 - 1.79 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:00:04 | 204 | $ 1.22 | USD |
Passage Bio Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
67.27M | 55.60M | - | 0 | -102.06M | -1.84 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Passage Bio News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PASG Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 1.25 | 1.28 | 1.1006 | 1.17 | 116,756 | -0.05 | -4.00% |
1 Month | 1.30 | 1.45 | 1.1006 | 1.30 | 141,494 | -0.10 | -7.69% |
3 Months | 0.97 | 1.79 | 0.9381 | 1.39 | 365,655 | 0.23 | 23.71% |
6 Months | 0.6792 | 1.79 | 0.5751 | 1.01 | 501,550 | 0.5208 | 76.68% |
1 Year | 1.01 | 1.79 | 0.5751 | 0.9652119 | 353,702 | 0.19 | 18.81% |
3 Years | 16.94 | 19.84 | 0.5751 | 4.05 | 332,054 | -15.74 | -92.92% |
5 Years | 22.27 | 38.23 | 0.5751 | 8.09 | 316,501 | -21.07 | -94.61% |
Passage Bio Description
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. |